Microbiota effects on cancer: from risks to therapies-Reference-Cited by-同舟云学术

Microbiota effects on cancer: from risks to therapies

Published:2018-04-03 Issue:25 Volume:9 Page:17915-17927
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Rea Domenica¹,Coppola Giovanni¹,Palma Giuseppe¹,Barbieri Antonio¹,Luciano Antonio¹,Del Prete Paola²,Rossetti Sabrina³,Berretta Massimiliano⁴,Facchini Gaetano³,Perdonà Sisto⁵,Turco Maria Caterina⁶,Arra Claudio¹

Affiliation:

1. S.S.D Sperimentazione Animale, Istituto Nazionale Tumori, IRCCS, “Fondazione G. Pascale”, Naples, Italy

2. Direzione Scientifica, Istituto Nazionale Tumori, IRCCS, “Fondazione G. Pascale”, Naples, Italy

3. Division of Medical Oncology, Department of Uro-Gynaecological Oncology, Istituto Nazionale Tumori, IRCCS, “Fondazione G. Pascale”, Naples, Italy

4. Department of Medical Oncology, CRO- Aviano, National Cancer Institute, Aviano, Italy

5. Department of Urology, Istituto Nazionale Tumori, IRCCS, “Fondazione G. Pascale”, Naples, Italy

6. Department of Medicine and Surgery, University of Salerno, Baronissi, Salerno, Italy

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 141 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting systemic and gut microbial metabolism in ER+ breast cancer;Trends in Endocrinology & Metabolism;2024-01

2. The role of intestinal flora on tumor immunotherapy: recent progress and treatment implications;Heliyon;2024-01

3. Gut microbiome as a tumor promoter and tumor suppressor;Microsphere;2023-12-25

4. Dietary supplementation of Patchouli oil increases the resistance against Streptococcus agalactiae infection in GIFT tilapia as revealed by transcriptome and 16s amplicon profiling;Aquaculture Reports;2023-12

5. Gut microbiome associated dysbiosis: Limited regimens and expanding horizons of phage therapy;Aspects of Molecular Medicine;2023-12